Clinical Trials Directory

Trials / Completed

CompletedNCT06957847

Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP)

Clinical Validation Of The Brachial Blood Pressure Measuring Device Withings BPM Pro 2 According To "The Universal Protocol For The Validation Of Blood Pressure Measuring Devices By The Association For The Advancement Of Medical Instrumentation / European Society Of Hypertension / International Organization For Standardization (AAMI/ESH/ISO) (And Its Amendment 1 (2020) And 2 (2024))" In The General Population.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
89 (actual)
Sponsor
Withings · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the brachial level, the WITHINGS BPM Pro 2, in the general population

Conditions

Interventions

TypeNameDescription
DEVICEBlood pressure measurementThe patient will be measured alternatively with a reference mercury sphygmomanometer (four times) and the device under study (3 times)

Timeline

Start date
2025-04-28
Primary completion
2025-08-21
Completion
2025-11-18
First posted
2025-05-05
Last updated
2026-02-18

Locations

1 site across 1 country: Armenia

Source: ClinicalTrials.gov record NCT06957847. Inclusion in this directory is not an endorsement.

Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP) (NCT06957847) · Clinical Trials Directory